{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:19:53Z","timestamp":1772605193977,"version":"3.50.1"},"reference-count":97,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>&amp;#916;&lt;sup&gt;9&lt;\/sup&gt;-Tetrahydrocannabinol (&amp;#916;&lt;sup&gt;9&lt;\/sup&gt;-THC), the active phytocannabinoid in cannabis, is virtually\nan adjunct to the endogenous endocannabinoid signaling system. By interacting with G-proteincoupled\nreceptors CB1 and CB2, &amp;#916;&lt;sup&gt;9&lt;\/sup&gt;-THC affects peripheral and central circulation by lowering\nsympathetic activity, altering gene expression, cell proliferation, and differentiation, decreasing\nleukocyte migration, modulating neurotransmitter release, thereby modulating cardiovascular functioning,\ntumorigenesis, immune responses, behavioral and locomotory activities. &amp;#916;&lt;sup&gt;9&lt;\/sup&gt;-THC effectively\nsuppresses chemotherapy-induced vomiting, retards malignant tumor growth, inhibits metastasis,\nand promotes apoptosis. Other mechanisms involved are targeting cell cycle at the G2-M phase\nin human breast cancer, downregulation of E2F transcription factor 1 (E2F1) in human glioblastoma\nmultiforme, and stimulation of ER stress-induced autophagy. &amp;#916;&lt;sup&gt;9&lt;\/sup&gt;-THC also plays a role in ameliorating\nneuroinflammation, excitotoxicity, neuroplasticity, trauma, and stroke and is associated\nwith reliving childhood epilepsy, brain trauma, and neurodegenerative diseases. &amp;#916;&lt;sup&gt;9&lt;\/sup&gt;-THC via CB1\nreceptors affects nociception, emotion, memory, and reduces neuronal excitability and excitotoxicity\nin epilepsy. It also increases renal blood flow, reduces intraocular pressure via a sympathetic\npathway, and modulates hormonal release, thereby decreasing the reproductive function and increasing\nglucose metabolism. Versatile medical marijuana has stimulated abundant research demonstrating\nsubstantial therapeutic promise, suggesting the possibilities of first-in-class drugs in diverse\ntherapeutic segments. This review represents the current pharmacological status of the phytocannabinoid,\n&amp;#916;&lt;sup&gt;9&lt;\/sup&gt;-THC, and synthetic analogs in cancer, cardiovascular, and neurodegenerative disorders.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450121666201001123515","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T13:24:37Z","timestamp":1601558677000},"page":"823-834","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An Agathokakological Tale of \u03949-THC: Exploration of Possible Biological Targets"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-4497","authenticated-orcid":true,"given":"Bijo","family":"Mathew","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seetha","family":"Harilal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arafa","family":"Musa","sequence":"additional","affiliation":[{"name":"Department of Pharmacogonosy, College of Pharmacy, Jouf University, Sakaka, Al Jouf, 2014,Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Della Grace Thomas","family":"Parambi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al Jouf, 2014,Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jobin","family":"Jose","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, NGSM Institute of Pharmaceutical Science, NITTE Deemed to be University, Manglore, 575018,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Sahab","family":"Uddin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Dhaka,Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ajmal","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pharmacogonosy, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad,Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazhuvancherry Kesavan","family":"Unnikrishnan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, National College of Pharmacy, Calicut,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Booth M.","year":"2005","unstructured":"Booth M.;  Cannabis: A History 2005","journal-title":"Cannabis: A History"},{"key":"ref=2","first-page":"363","volume":"5","author":"O\u2019Shaughnessy W.B.","year":"1843","unstructured":"O\u2019Shaughnessy W.B.; On the preparations of the Indian hemp, or Gunjah: Cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Prov Med J Retrosp Med Sci 1843,5(123),363","journal-title":"Prov Med J Retrosp Med Sci"},{"key":"ref=3","author":"Sandeep C.","year":"2011","unstructured":"Sandeep C.;  World drug report 2011 2011","journal-title":"World drug report 2011"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/02791072.1981.10471447","volume":"13","author":"Touw M.","year":"1981","unstructured":"Touw M.; The religious and medicinal uses of Cannabis in China, India and Tibet. J Psychoactive Drugs 1981,13(1),23-34","journal-title":"J Psychoactive Drugs"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-126-10-199705150-00008","volume":"126","author":"Voth E.A.","year":"1997","unstructured":"Voth E.A.; Schwartz R.H.; Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann Intern Med 1997,126(10),791-798","journal-title":"Ann Intern Med"},{"key":"ref=6","first-page":"1093","volume":"3","author":"ElSohly M.","year":"2014","unstructured":"ElSohly M.; Gul W.; Constituents of cannabis sativa. Handb Cannabis 2014,3,1093","journal-title":"Handb Cannabis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1021\/ja01092a065","volume":"87","author":"Mechoulam R.","year":"1965","unstructured":"Mechoulam R.; Gaoni Y.; A total synthesis of dl-\u03941-tetrahydrocannabinol, the active constituent of hashish1. J Am Chem Soc 1965,87(14),3273-3275","journal-title":"J Am Chem Soc"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Gaoni Y.","year":"1964","unstructured":"Gaoni Y.; Mechoulam R.; Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964,86(8),1646-1647","journal-title":"J Am Chem Soc"},{"key":"ref=9","unstructured":"delta9-Tetrahydrocannabinol  https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2978"},{"key":"ref=10","first-page":"149","volume":"7","author":"Sharma P.","year":"2012","unstructured":"Sharma P.; Murthy P.; Bharath M.M.; Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iran J Psychiatry 2012,7(4),149-156","journal-title":"Iran J Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(03)00381-8","volume":"2","author":"Baker D.","year":"2003","unstructured":"Baker D.; Pryce G.; Giovannoni G.; Thompson A.J.; The therapeutic potential of cannabis. Lancet Neurol 2003,2(5),291-298","journal-title":"Lancet Neurol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","volume":"172","author":"McPartland J.M.","year":"2015","unstructured":"McPartland J.M.; Duncan M.; Di Marzo V.; Pertwee R.G.; Are cannabidiol and \u0394(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol 2015,172(3),737-753","journal-title":"Br J Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","volume":"13","author":"Howlett A.C.","year":"1990","unstructured":"Howlett A.C.; Bidaut-Russell M.; Devane W.A.; Melvin L.S.; Johnson M.R.; Herkenham M.; The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci 1990,13(10),420-423","journal-title":"Trends Neurosci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0009-3084(02)00153-6","volume":"121","author":"Mukhopadhyay S.","year":"2002","unstructured":"Mukhopadhyay S.; Shim J-Y.; Assi A-A.; Norford D.; Howlett A.C.; CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. Chem Phys Lipids 2002,121(1-2),91-109","journal-title":"Chem Phys Lipids"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1124\/mol.107.039263","volume":"72","author":"Niehaus J.L.","year":"2007","unstructured":"Niehaus J.L.; Liu Y.; Wallis K.T.; Egertov\u00e1 M.; Bhartur S.G.; Mukhopadhyay S.; Shi S.; He H.; Selley D.E.; Howlett A.C.; Elphick M.R.; Lewis D.L.; CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Mol Pharmacol 2007,72(6),1557-1566","journal-title":"Mol Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/BF00401256","volume":"11","author":"Isbell H.","year":"1967","unstructured":"Isbell H.; Gorodetzsky C.W.; Jasinski D.; Claussen U.; von Spulak F.; Korte F.; Effects of (--)\u03b4-9-trans-tetrahydrocannabinol in man. Psychopharmacology (Berl) 1967,11(2),184-188","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.pa.35.040195.003135","volume":"35","author":"Howlett A.C.","year":"1995","unstructured":"Howlett A.C.; Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 1995,35(1),607-634","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0304-3959(01)00321-9","volume":"93","author":"Malan T.P.","year":"2001","unstructured":"Malan T.P.; Ibrahim M.M.; Deng H.; Liu Q.; Mata H.P.; Vanderah T.; Porreca F.; Makriyannis A.; CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 2001,93(3),239-245","journal-title":"Pain"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/eje.0.1470255","volume":"147","author":"Porcella A.","year":"2002","unstructured":"Porcella A.; Marchese G.; Casu M.A.; Rocchitta A.; Lai M.L.; Gessa G.L.; Pani L.; Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. Eur J Endocrinol 2002,147(2),255-261","journal-title":"Eur J Endocrinol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"Ryberg E.","year":"2007","unstructured":"Ryberg E.; Larsson N.; Sj\u00f6gren S.; Hjorth S.; Hermansson N-O.; Leonova J.; Elebring T.; Nilsson K.; Drmota T.; Greasley P.J.; The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007,152(7),1092-1101","journal-title":"Br J Pharmacol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","volume":"6","author":"Pertwee R.G.","year":"1999","unstructured":"Pertwee R.G.; Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999,6(8),635-664","journal-title":"Curr Med Chem"},{"key":"ref=22","first-page":"605","volume":"34","author":"Devane W.A.","year":"1988","unstructured":"Devane W.A.; Dysarz F.A.; Johnson M.R.; Melvin L.S.; Howlett A.C.; Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988,34(5),605-613","journal-title":"Mol Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/BF00174068","volume":"90","author":"Bhattacharya S.K.","year":"1986","unstructured":"Bhattacharya S.K.; delta-9-tetrahydrocannabinol (THC) increases brain prostaglandins in the rat. Psychopharmacology (Berl) 1986,90(4),499-502","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3109\/10826088509044289","volume":"20","author":"Ungerleider J.T.","year":"1985","unstructured":"Ungerleider J.T.; Andrysiak T.; Therapeutic issues of marijuana and THC (tetrahydrocannabinol). Int J Addict 1985,20(5),691-699","journal-title":"Int J Addict"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pnpbp.2012.02.006","volume":"38","author":"Bambico F.R.","year":"2012","unstructured":"Bambico F.R.; Hattan P.R.; Garant J-P.; Gobbi G.; Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission. Prog Neuropsychopharmacol Biol Psychiatry 2012,38(1),88-96","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature20153","volume":"539","author":"Bloomfield M.A.","year":"2016","unstructured":"Bloomfield M.A.; Ashok A.H.; Volkow N.D.; Howes O.D.; The effects of \u0394-tetrahydrocannabinol on the dopamine system. Nature 2016,539(7629),369-377","journal-title":"Nature"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41380-019-0374-8","author":"Colizzi M.","year":"2019","unstructured":"Colizzi M.; Weltens N.; McGuire P.; Lythgoe D.; Williams S.; Van Oudenhove L.; Bhattacharyya S.; Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Mol Psychiatry 2019,1-10","journal-title":"Mol Psychiatry"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neuroscience.2007.10.026","volume":"151","author":"Sano K.","year":"2008","unstructured":"Sano K.; Mishima K.; Koushi E.; Orito K.; Egashira N.; Irie K.; Takasaki K.; Katsurabayashi S.; Iwasaki K.; Uchida N.; Egawa T.; Kitamura Y.; Nishimura R.; Fujiwara M.; \u0394 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Neuroscience 2008,151(2),320-328","journal-title":"Neuroscience"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1476-5381.2008.00048.x","volume":"156","author":"Pertwee R.G.","year":"2009","unstructured":"Pertwee R.G.; Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 2009,156(3),397-411","journal-title":"Br J Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35003583","volume":"404","author":"Baker D.","year":"2000","unstructured":"Baker D.; Pryce G.; Croxford J.L.; Brown P.; Pertwee R.G.; Huffman J.W.; Layward L.; Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000,404(6773),84-87","journal-title":"Nature"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/14660820310016813","volume":"5","author":"Raman C.","year":"2004","unstructured":"Raman C.; McAllister S.D.; Rizvi G.; Patel S.G.; Moore D.H.; Abood M.E.; Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler Other Motor Neuron Disord 2004,5(1),33-39","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","volume":"1134","author":"Garc\u00eda-Arencibia M.","year":"2007","unstructured":"Garc\u00eda-Arencibia M.; Gonz\u00e1lez S.; de Lago E.; Ramos J.A.; Mechoulam R.; Fern\u00e1ndez-Ruiz J.; Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson\u2019s disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res 2007,1134(1),162-170","journal-title":"Brain Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","volume":"163","author":"Fern\u00e1ndez-Ruiz J.","year":"2011","unstructured":"Fern\u00e1ndez-Ruiz J.; Moreno-Martet M.; Rodr\u00edguez-Cueto C.; Palomo-Garo C.; G\u00f3mez-Ca\u00f1as M.; Valdeolivas S.; Guaza C.; Romero J.; Guzm\u00e1n M.; Mechoulam R.; Ramos J.A.; Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol 2011,163(7),1365-1378","journal-title":"Br J Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e12920","DOI":"10.1111\/eci.12920","volume":"48","author":"Calabrese E.J.","year":"2018","unstructured":"Calabrese E.J.; Rubio-Casillas A.; Biphasic effects of THC in memory and cognition. Eur J Clin Invest 2018,48(5),e12920","journal-title":"Eur J Clin Invest"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.brainresbull.2020.03.018","volume":"160","author":"Harilal S.","year":"2020","unstructured":"Harilal S.; Jose J.; Parambi D.G.T.; Kumar R.; Unnikrishnan M.K.; Uddin M.S.; Mathew G.E.; Pratap R.; Marathakam A.; Mathew B.; Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules. Brain Res Bull 2020,160,121-140","journal-title":"Brain Res Bull"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00018-006-6037-3","volume":"63","author":"van der Stelt M.","year":"2006","unstructured":"van der Stelt M.; Mazzola C.; Esposito G.; Matias I.; Petrosino S.; De Filippis D.; Micale V.; Steardo L.; Drago F.; Iuvone T.; Di Marzo V.; Endocannabinoids and \u03b2-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci 2006,63(12),1410-1424","journal-title":"Cell Mol Life Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00213-006-0343-1","volume":"185","author":"Walther S.","year":"2006","unstructured":"Walther S.; Mahlberg R.; Eichmann U.; Kunz D.; Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology (Berl) 2006,185(4),524-528","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.3390\/molecules17033524","volume":"17","author":"Yoo K-Y.","year":"2012","unstructured":"Yoo K-Y.; Park S-Y.; Terpenoids as potential anti-Alzheimer\u2019s disease therapeutics. Molecules 2012,17(3),3524-3538","journal-title":"Molecules"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/mp060066m","volume":"3","author":"Eubanks L.M.","year":"2006","unstructured":"Eubanks L.M.; Rogers C.J.; Beuscher A.E.; Koob G.F.; Olson A.J.; Dickerson T.J.; Janda K.D.; A molecular link between the active component of marijuana and Alzheimer\u2019s disease pathology. Mol Pharm 2006,3(6),773-777","journal-title":"Mol Pharm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00192-006-0086-x","volume":"17","author":"Freeman R.M.","year":"2006","unstructured":"Freeman R.M.; Adekanmi O.; Waterfield M.R.; Waterfield A.E.; Wright D.; Zajicek J.; The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 2006,17(6),636-641","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","volume":"362","author":"Zajicek J.","year":"2003","unstructured":"Zajicek J.; Fox P.; Sanders H.; Wright D.; Vickery J.; Nunn A.; Thompson A.; Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet UK MS Research Group2003,362(9395),1517-1526","journal-title":"Lancet"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","volume":"76","author":"Zajicek J.P.","year":"2005","unstructured":"Zajicek J.P.; Sanders H.P.; Wright D.E.; Vickery P.J.; Ingram W.M.; Reilly S.M.; Nunn A.J.; Teare L.J.; Fox P.J.; Thompson A.J.; Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry 2005,76(12),1664-1669","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=43","first-page":"941","volume":"239","author":"Campbell K.A.","year":"1986","unstructured":"Campbell K.A.; Foster T.C.; Hampson R.E.; Deadwyler S.A.; Effects of delta 9-tetrahydrocannabinol on sensory-evoked discharges of granule cells in the dentate gyrus of behaving rats. J Pharmacol Exp Ther 1986,239(3),941-945","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40429-017-0142-2","volume":"4","author":"Colizzi M.","year":"2017","unstructured":"Colizzi M.; Bhattacharyya S.; Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition. Curr Addict Rep 2017,4(2),62-74","journal-title":"Curr Addict Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02190083","volume":"240","author":"Maurer M.","year":"1990","unstructured":"Maurer M.; Henn V.; Dittrich A.; Hofmann A.; Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Neurosci 1990,240(1),1-4","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1300\/J251v07n01_04","volume":"7","author":"Ungerleider J.T.","year":"1987","unstructured":"Ungerleider J.T.; Andyrsiak T.; Fairbanks L.; Ellison G.W.; Myers L.W.; Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse 1987,7(1),39-50","journal-title":"Adv Alcohol Subst Abuse"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.16202","author":"Slomski A.","year":"2018","unstructured":"Slomski A.; THC for Chronic Pain. JAMA 2018 https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2708108","journal-title":"JAMA"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4613-4286-1_4","author":"Green K.","year":"1976","unstructured":"Green K.; Kim K.; Bowman K.;  The Therapeutic Potential of Marihuana 1976,49-62","journal-title":"The Therapeutic Potential of Marihuana"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0306-3623(80)90026-9","volume":"11","author":"Korczyn A.D.","year":"1980","unstructured":"Korczyn A.D.; The ocular effects of cannabinoids. Gen Pharmacol 1980,11(5),419-423","journal-title":"Gen Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archopht.1982.01030030267006","volume":"100","author":"Green K.","year":"1982","unstructured":"Green K.; Roth M.; Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man. Arch Ophthalmol 1982,100(2),265-267","journal-title":"Arch Ophthalmol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/00952990.2019.1627366","volume":"45","author":"Tashkin D.P.","year":"2019","unstructured":"Tashkin D.P.; Roth M.D.; Pulmonary effects of inhaled cannabis smoke. Am J Drug Alcohol Abuse 2019,45(6),596-609","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000494992","volume":"1","author":"Pergolizzi J.V.","year":"2018","unstructured":"Pergolizzi J.V.; LeQuang J.A.; Bisney J.F.; Cannabinoid hyperemesis. Med Cannabis Cannabinoids 2018,1(2),73-95","journal-title":"Med Cannabis Cannabinoids"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0091-6773(75)91684-3","volume":"15","author":"Abel E.L.","year":"1975","unstructured":"Abel E.L.; Cannabis: effects on hunger and thirst. Behav Biol 1975,15(3),255-281","journal-title":"Behav Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e13370","DOI":"10.1111\/nmo.13370","volume":"30","author":"Camilleri M.","year":"2018","unstructured":"Camilleri M.; Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans. Neurogastroenterol Motil 2018,30(9),e13370","journal-title":"Neurogastroenterol Motil"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/cpt1972135part1671","volume":"13","author":"Weiss J.L.","year":"1972","unstructured":"Weiss J.L.; Watanabe A.M.; Lemberger L.; Tamarkin N.R.; Cardon P.V.; Cardiovascular effects of delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther 1972,13(5),671-684","journal-title":"Clin Pharmacol Ther"},{"key":"ref=56","author":"Iversen L.L.","year":"2001","unstructured":"Iversen L.L.;  The science of marijuana 2001","journal-title":"The science of marijuana"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1006\/nbdi.1998.0224","volume":"5","author":"Murphy L.L.","year":"1998","unstructured":"Murphy L.L.; Mu\u00f1oz R.M.; Adrian B.A.; Villan\u00faa M.A.; Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 1998,5(6 Pt B),432-446","journal-title":"Neurobiol Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0024-3205(74)90223-9","volume":"15","author":"Kokka N.","year":"1974","unstructured":"Kokka N.; Garcia J.F.; Effects of delta 9-THC on growth hormone and ACTH secretion in rats. Life Sci 1974,15(2),329-338","journal-title":"Life Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0014-2999(70)90094-4","volume":"12","author":"Dewey W.L.","year":"1970","unstructured":"Dewey W.L.; Peng T-C.; Harris L.S.; The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats. Eur J Pharmacol 1970,12(3),382-384","journal-title":"Eur J Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"10063","DOI":"10.1073\/pnas.87.24.10063","volume":"87","author":"Rettori V.","year":"1990","unstructured":"Rettori V.; Aguila M.C.; Gimeno M.F.; Franchi A.M.; McCann S.M.; In vitro effect of delta 9-tetrahydrocannabinol to stimulate somatostatin release and block that of luteinizing hormone-releasing hormone by suppression of the release of prostaglandin E2. Proc Natl Acad Sci USA 1990,87(24),10063-10066","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0091-3057(84)90303-4","volume":"20","author":"Hillard C.J.","year":"1984","unstructured":"Hillard C.J.; Farber N.E.; Hagen T.C.; Bloom A.S.; The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmacol Biochem Behav 1984,20(4),547-550","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/0006-2952(86)90733-1","volume":"35","author":"Laychock S.G.","year":"1986","unstructured":"Laychock S.G.; Hoffman J.M.; Meisel E.; Bilgin S.; Pancreatic islet arachidonic acid turnover and metabolism and insulin release in response to delta-9-tetrahydrocannabinol. Biochem Pharmacol 1986,35(12),2003-2008","journal-title":"Biochem Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000137763","volume":"26","author":"Baczynsky W.O.","year":"1983","unstructured":"Baczynsky W.O.; Zimmerman A.M.; Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response. Pharmacology 1983,26(1),1-11","journal-title":"Pharmacology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0162-3109(93)90005-B","volume":"26","author":"Schatz A.R.","year":"1993","unstructured":"Schatz A.R.; Koh W.S.; Kaminski N.E.\u0394.; Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology 1993,26(2),129-137","journal-title":"Immunopharmacology"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"Gali\u00e8gue S.","year":"1995","unstructured":"Gali\u00e8gue S.; Mary S.; Marchand J.; Dussossoy D.; Carri\u00e8re D.; Carayon P.; Bouaboula M.; Shire D.; Le Fur G.; Casellas P.; Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995,232(1),54-61","journal-title":"Eur J Biochem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/cancers2021013","volume":"2","author":"Massi P.","year":"2010","unstructured":"Massi P.; Valenti M.; Solinas M.; Parolaro D.; Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress. Cancers (Basel) 2010,2(2),1013-1026","journal-title":"Cancers (Basel)"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1210\/en.2009-0883","volume":"151","author":"Guida M.","year":"2010","unstructured":"Guida M.; Ligresti A.; De Filippis D.; D\u2019Amico A.; Petrosino S.; Cipriano M.; Bifulco G.; Simonetti S.; Orlando P.; Insabato L.; Nappi C.; Di Spiezio Sardo A.; Di Marzo V.; Iuvone T.; The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma. Endocrinology 2010,151(3),921-928","journal-title":"Endocrinology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc1188","volume":"3","author":"Guzm\u00e1n M.","year":"2003","unstructured":"Guzm\u00e1n M.; Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003,3(10),745-755","journal-title":"Nat Rev Cancer"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1158\/0008-5472.CAN-07-2785","volume":"68","author":"Sarfaraz S.","year":"2008","unstructured":"Sarfaraz S.; Adhami V.M.; Syed D.N.; Afaq F.; Mukhtar H.; Cannabinoids for cancer treatment: progress and promise. Cancer Res 2008,68(2),339-342","journal-title":"Cancer Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.pnpbp.2015.05.010","volume":"64","author":"Velasco G.","year":"2016","unstructured":"Velasco G.; Hern\u00e1ndez-Tiedra S.; D\u00e1vila D.; Lorente M.; The use of cannabinoids as anticancer agents. Prog Neuropsychopharmacol Biol Psychiatry 2016,64,259-266","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/j.1476-5381.2011.01327.x","volume":"163","author":"Guindon J.","year":"2011","unstructured":"Guindon J.; Hohmann A.G.; The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol 2011,163(7),1447-1463","journal-title":"Br J Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1158\/0008-5472.CAN-05-4566","volume":"66","author":"Caffarel M.M.","year":"2006","unstructured":"Caffarel M.M.; Sarri\u00f3 D.; Palacios J.; Guzm\u00e1n M.; S\u00e1nchez C.; Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res 2006,66(13),6615-6621","journal-title":"Cancer Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tox.2014.09.011","volume":"326","author":"Takeda S.","year":"2014","unstructured":"Takeda S.; Ikeda E.; Su S.; Harada M.; Okazaki H.; Yoshioka Y.; Nishimura H.; Ishii H.; Kakizoe K.; Taniguchi A.; Tokuyasu M.; Himeno T.; Watanabe K.; Omiecinski C.J.; Aramaki H.; \u0394(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPAR\u03b1 in MDA-MB-231 breast cancer cells. Toxicology 2014,326,18-24","journal-title":"Toxicology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/ijms20071673","volume":"20","author":"Kiskov\u00e1 T.","year":"2019","unstructured":"Kiskov\u00e1 T.; Mungenast F.; Suv\u00e1kov\u00e1 M.; J\u00e4ger W.; Thalhammer T.; Future Aspects for cannabinoids in breast cancer therapy. Int J Mol Sci 2019,20(7),1673","journal-title":"Int J Mol Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1158\/0008-5472.CAN-06-0169","volume":"66","author":"Carracedo A.","year":"2006","unstructured":"Carracedo A.; Gironella M.; Lorente M.; Garcia S.; Guzm\u00e1n M.; Velasco G.; Iovanna J.L.; Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 2006,66(13),6748-6755","journal-title":"Cancer Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bcp.2018.06.025","volume":"157","author":"Blasco-Benito S.","year":"2018","unstructured":"Blasco-Benito S.; Seijo-Vila M.; Caro-Villalobos M.; Tundidor I.; Andradas C.; Garc\u00eda-Taboada E.; Wade J.; Smith S.; Guzm\u00e1n M.; P\u00e9rez-G\u00f3mez E.; Gordon M.; S\u00e1nchez C.; Appraising the \u201centourage effect\u201d: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem Pharmacol 2018,157,285-293","journal-title":"Biochem Pharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/pancan.2018.0019","volume":"5","author":"Sharafi G.","year":"2019","unstructured":"Sharafi G.; He H.; Nikfarjam M.; Potential use of cannabinoids for the treatment of pancreatic cancer. J Pancreat Cancer 2019,5(1),1-7","journal-title":"J Pancreat Cancer"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1080\/02841860701678787","volume":"47","author":"Galanti G.","year":"2008","unstructured":"Galanti G.; Fisher T.; Kventsel I.; Shoham J.; Gallily R.; Mechoulam R.; Lavie G.; Amariglio N.; Rechavi G.; Toren A.; \u0394 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncol 2008,47(6),1062-1070","journal-title":"Acta Oncol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI37948","volume":"119","author":"Salazar M.","year":"2009","unstructured":"Salazar M.; Carracedo A.; Salanueva \u00cd.J.; Hern\u00e1ndez-Tiedra S.; Lorente M.; Egia A.; V\u00e1zquez P.; Bl\u00e1zquez C.; Torres S.; Garc\u00eda S.; Nowak J.; Fimia G.M.; Piacentini M.; Cecconi F.; Pandolfi P.P.; Gonz\u00e1lez-Feria L.; Iovanna J.L.; Guzm\u00e1n M.; Boya P.; Velasco G.; Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 2009,119(5),1359-1372","journal-title":"J Clin Invest"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-14-0402","volume":"13","author":"Scott K.A.","year":"2014","unstructured":"Scott K.A.; Dalgleish A.G.; Liu W.M.; The combination of cannabidiol and \u03949-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model. Mol Cancer Ther 2014,13(12),2955-2967","journal-title":"Mol Cancer Ther"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bcp.2018.09.007","volume":"157","author":"L\u00f3pez-Valero I.","year":"2018","unstructured":"L\u00f3pez-Valero I.; Saiz-Ladera C.; Torres S.; Hern\u00e1ndez-Tiedra S.; Garc\u00eda-Taboada E.; Rodr\u00edguez-Forn\u00e9s F.; Barba M.; D\u00e1vila D.; Salvador-Tormo N.; Guzm\u00e1n M.; Sep\u00falveda J.M.; S\u00e1nchez-G\u00f3mez P.; Lorente M.; Velasco G.; Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide. Biochem Pharmacol 2018,157,266-274","journal-title":"Biochem Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/jid.2015.45","volume":"135","author":"Armstrong J.L.","year":"2015","unstructured":"Armstrong J.L.; Hill D.S.; McKee C.S.; Hernandez-Tiedra S.; Lorente M.; Lopez-Valero I.; Eleni Anagnostou M.; Babatunde F.; Corazzari M.; Redfern C.P.F.; Velasco G.; Lovat P.E.; Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J Invest Dermatol 2015,135(6),1629-1637","journal-title":"J Invest Dermatol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.3892\/ol.2018.8407","volume":"15","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Zheng W.; Shen K.; Shen W.; \u22069-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer. Oncol Lett 2018,15(6),8527-8535","journal-title":"Oncol Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"Grotenhermen F.","year":"2003","unstructured":"Grotenhermen F.; Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003,42(4),327-360","journal-title":"Clin Pharmacokinet"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"Huestis M.A.","year":"2007","unstructured":"Huestis M.A.; Human cannabinoid pharmacokinetics. Chem Biodivers 2007,4(8),1770-1804","journal-title":"Chem Biodivers"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/can.2016.0008","volume":"1","author":"Moreno-Sanz G.","year":"2016","unstructured":"Moreno-Sanz G.; Can you pass the acid test? critical review and novel therapeutic perspectives of a 9-tetrahydrocannabinolic acid a. Cannabis Cannabinoid Res 2016,1(1),124-30","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.173.3991.72","volume":"173","author":"Lemberger L.","year":"1971","unstructured":"Lemberger L.; Tamarkin N.R.; Axelrod J.; Kopin I.J.; Delta-9-tetrahydrocannabinol: metabolism and disposition in long-term marihuana smokers. Science 1971,173(3991),72-74","journal-title":"Science"},{"key":"ref=88","author":"O\u2019Donnell B.","year":"2020","unstructured":"O\u2019Donnell B.; Gupta V.;  StatPearls 2020","journal-title":"StatPearls"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/00952999309001618","volume":"19","author":"Gable R.S.","year":"1993","unstructured":"Gable R.S.; Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically. Am J Drug Alcohol Abuse 1993,19(3),263-281","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-139-4-200308190-00008","volume":"139","author":"Abrams D.I.","year":"2003","unstructured":"Abrams D.I.; Hilton J.F.; Leiser R.J.; Shade S.B.; Elbeik T.A.; Aweeka F.T.; Benowitz N.L.; Bredt B.M.; Kosel B.; Aberg J.A.; Deeks S.G.; Mitchell T.F.; Mulligan K.; Bacchetti P.; McCune J.M.; Schambelan M.; Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 2003,139(4),258-266","journal-title":"Ann Intern Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2249.2005.02803.x","volume":"140","author":"Katona S.","year":"2005","unstructured":"Katona S.; Kaminski E.; Sanders H.; Zajicek J.; Cannabinoid influence on cytokine profile in multiple sclerosis. Clin Exp Immunol 2005,140(3),580-585","journal-title":"Clin Exp Immunol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/tera.1420110112","volume":"11","author":"Banerjee B.N.","year":"1975","unstructured":"Banerjee B.N.; Galbreath C.; Sofia R.D.; Teratologic evaluation of synthetic delta-9-tetrahydrocannabinol in rats. Teratology 1975,11(1),99-101","journal-title":"Teratology"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0041-008X(71)90252-3","volume":"20","author":"Borgen L.A.","year":"1971","unstructured":"Borgen L.A.; Davis W.M.; Pace H.B.; Effects of synthetic 9 -tetrahydrocannabinol on pregnancy and offspring in the rat. Toxicol Appl Pharmacol 1971,20(4),480-486","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=94","first-page":"455","volume":"202","author":"Harbison R.D.","year":"1977","unstructured":"Harbison R.D.; Mantilla-Plata B.; Lubin D.J.; Alteration of delta 9-tetrahydrocannabinol-induced teratogenicity by stimulation and inhibition of its metabolism. J Pharmacol Exp Ther 1977,202(2),455-465","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/archinte.167.3.221","volume":"167","author":"Tetrault J.M.","year":"2007","unstructured":"Tetrault J.M.; Crothers K.; Moore B.A.; Mehra R.; Concato J.; Fiellin D.A.; Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007,167(3),221-228","journal-title":"Arch Intern Med"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"L298","DOI":"10.1152\/ajplung.00157.2002","volume":"284","author":"Sarafian T.A.","year":"2003","unstructured":"Sarafian T.A.; Kouyoumjian S.; Khoshaghideh F.; Tashkin D.P.; Roth M.D.\u0394.; Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am J Physiol Lung Cell Mol Physiol 2003,284(2),L298-L306","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1165\/ajrcmb.20.6.3424","volume":"20","author":"Sarafian T.A.","year":"1999","unstructured":"Sarafian T.A.; Magallanes J.A.M.; Shau H.; Tashkin D.; Roth M.D.; Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol 1999,20(6),1286-1293","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450121666201001123515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186455\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450121666201001123515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T06:04:30Z","timestamp":1660716270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186455\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450121666201001123515","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}